News
Vitamin D may decrease colon cancer risk
9 February 2011
High blood levels of vitamin D are associated with a reduced risk of colorectal cancer, according to a new French analysis.
28 September 2009
A combination of omega-3 fatty acids and coenzyme Q10 may decrease blood pressure and heart rate in kidney disease patients, reports a new study.
The results of the randomized controlled trial showed that people with chronic kidney disease (CKD) receiving omega-3 fatty acids (4 grams) for 8 weeks experienced a 3.3 and 2.9 mmHg decrease in systolic and diastolic blood pressure, and a reduction of heart rate of 4.0 beats per minute (1). Furthermore, triglyceride levels decreased by 24 percent in this group.
In the group receiving omega-3 fatty acids plus coenzyme Q10 (200 mg), systolic and diastolic blood pressure improved by 2.7 and 3.4 mmHg, respectively. CoQ10 did not benefit blood pressure and was associated with a slight increase in heart rate.
The researchers commented that the finding of an interaction between omega-3 fatty acids and CoQ10 on blood pressure is difficult to explain in view of the lack of effect of CoQ10 alone on blood pressure and needs confirmation.
According to the publication, CKD increases the risk of heart disease two- to 50-fold and increases the prevalence of all-cause mortality and hospitalization. Modifiable risk factors include high blood pressure (hypertension). By lowering blood pressure, omega-3 fatty acids may reduce cardiovascular risk in non-diabetic patients with moderate-to-severe CKD.
9 February 2011
High blood levels of vitamin D are associated with a reduced risk of colorectal cancer, according to a new French analysis.
22 February 2016
In the USA, 50% of people aged 70 years or older did not consume the EAR (Estimated Average Requirement) for vitamins D, E and K, and 35 to 40% for vitamins C and A. Whilst for the B vitamins, the percentage of older people failing to meet the EAR was between 1 and 30%.
10 April 2015
Research from Choi et al. of the Linus Pauling Institute at Oregon State University has used lipodomics to demonstrate that alpha tocopherol protects key brain lyso-phospholipids from oxidation, notably those based on Docahexaenoic Acid (DHA) in a zebrafish model.